The FSH receptor has also been shown to affect stemness and proliferation in mesenchymal stem cells (MSC) associated with osteoclast prevalence in bone marrow.29 FSH receptors are also expressed by endothelial cells in the blood vessels of a wide range of tumors in patients.30,31 The present approach could provide new tools for monitoring tumor progression in vivo. Here, FSHR is linked to neoplasm.